160 related articles for article (PubMed ID: 37002409)
1. Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis.
Luther M; Henes FO; Zabelina T; Massoud R; Janson D; Wolschke C; Klyuchnikov E; Gagelmann N; Fehse B; Adam G; Kröger N; Ayuk F
Bone Marrow Transplant; 2023 Jul; 58(7):755-761. PubMed ID: 37002409
[TBL] [Abstract][Full Text] [Related]
2. Enlarged spleen is associated with low neutrophil and platelet engraftment rates and poor survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome.
Shimomura Y; Hara M; Katoh D; Hashimoto H; Ishikawa T
Ann Hematol; 2018 Jun; 97(6):1049-1056. PubMed ID: 29455235
[TBL] [Abstract][Full Text] [Related]
3. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
[TBL] [Abstract][Full Text] [Related]
4. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly.
Ito T; Akagi K; Kondo T; Kawabata H; Ichinohe T; Takaori-Kondo A
Tohoku J Exp Med; 2012 Dec; 228(4):295-9. PubMed ID: 23117264
[TBL] [Abstract][Full Text] [Related]
5. Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT.
Kröger N; Sbianchi G; Sirait T; Wolschke C; Beelen D; Passweg J; Robin M; Vrhovac R; Helbig G; Sockel K; Conneally E; Rubio MT; Beguin Y; Finke J; Bernasconi P; Morozova E; Clausen J; von dem Borne P; Schaap N; Schroyens W; Patriarca F; Di Renzo N; Yeğin ZA; Hayden P; McLornan D; Yakoub-Agha I
Leukemia; 2021 Dec; 35(12):3551-3560. PubMed ID: 34023851
[TBL] [Abstract][Full Text] [Related]
6. Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry.
Lwin Y; Kennedy G; Gottlieb D; Kwan J; Ritchie D; Szer J; Milliken S; Browett P; Spencer A; Butler A; Bardy P; Greenwood M; Perera T; He S; McEwan A; Larsen S; Lai H; Purtill D; Tran S; Aarons D; Hamad N
Biol Blood Marrow Transplant; 2020 Dec; 26(12):2252-2261. PubMed ID: 32861814
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis.
Alchalby H; Yunus DR; Zabelina T; Ayuk F; Kröger N
Bone Marrow Transplant; 2016 Sep; 51(9):1223-7. PubMed ID: 27088376
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction.
Li VWK; Yim R; Lee P; Chin L; Au L; Leung GMK; Sim J; Lie AKW; Tse E; Kwong YL; Gill H
Ann Hematol; 2023 Sep; 102(9):2517-2527. PubMed ID: 37329451
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.
Gergis U; Kuriakose E; Shore T; Mayer S; Mark T; Pearse R; Schuster M; Feldman E; Roboz G; Ritchie E; Scandura J; Wang H; Zhou XK; Silver RT; van Besien K
Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):297-303. PubMed ID: 27025789
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase Myelofibrosis.
Keyzner A; Han S; Shapiro S; Moshier E; Schorr E; Petersen B; Najfeld V; Kremyanskaya M; Isola L; Hoffman R; Mascarenhas J
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2180-2186. PubMed ID: 27596130
[TBL] [Abstract][Full Text] [Related]
11. Nonfluorodeoxyglucose-Avid Persistent Splenomegaly at Time of Transplantation Delays Neutrophil and Platelets Engraftment without Affecting Survival in Patients with Lymphomas Undergoing Allogeneic Hematopoietic Cell Transplantation.
Khimani F; Jeong DK; Miladinovic B; Nishihori T; Ayala E; Locke F; Mishra A; Chavez J; Shah B; Gage K; Kharfan-Dabaja MA
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2201-2207. PubMed ID: 27660169
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib.
Jaekel N; Behre G; Behning A; Wickenhauser C; Lange T; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2014 Feb; 49(2):179-84. PubMed ID: 24292520
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT.
McLornan DP; Szydlo R; Robin M; van Biezen A; Koster L; Blok HJP; Van Lint MT; Finke J; Vitek A; Carlson K; Griskevicius L; Holler E; Itälä-Remes M; Schaap M; Socié G; Bay JO; Beguin Y; Bruno B; Cornelissen JJ; Gedde-Dahl T; Ljungman P; Rubio MT; Yakoub-Agha I; Klyuchnikov E; Olavarria E; Chalandon Y; Kröger N
Br J Haematol; 2018 Aug; 182(3):418-422. PubMed ID: 29808926
[TBL] [Abstract][Full Text] [Related]
14. Volumetric splenomegaly in patients with essential thrombocythemia and prefibrotic/early primary myelofibrosis.
Lee MW; Yeon SH; Ryu H; Song IC; Lee HJ; Yun HJ; Kim SY; Lee JE; Shin KS; Jo DY
Int J Hematol; 2021 Jul; 114(1):35-43. PubMed ID: 33704663
[TBL] [Abstract][Full Text] [Related]
15. Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML).
Pohlmann A; Bentgens E; Schülke C; Kuron D; Reicherts C; Marx J; Angenendt L; Mikesch JH; Lenz G; Stelljes M; Schliemann C
Ann Hematol; 2023 Sep; 102(9):2543-2553. PubMed ID: 37428201
[TBL] [Abstract][Full Text] [Related]
16. [Successful management of splenomegaly with ruxolitinib prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia transformed from post-polycythemia vera myelofibrosis].
Fujishima M; Fujishima N; Kitadate A; Guo Y; Watanabe A; Ubukawa K; Nara M; Yoshioka T; Kameoka Y; Takahashi N
Rinsho Ketsueki; 2017; 58(7):743-748. PubMed ID: 28781268
[TBL] [Abstract][Full Text] [Related]
17. Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT).
Polverelli N; Mauff K; Kröger N; Robin M; Beelen D; Beauvais D; Chevallier P; Mohty M; Passweg J; Rubio MT; Maertens J; Finke J; Bornhäuser M; Vrhovac R; Helbig G; Mear JB; Castagna L; Reményi P; Angelucci E; Karakasis D; Rifòn J; Sirait T; Russo D; de Wreede L; Czerw T; Hernández-Boluda JC; Hayden P; McLornan D; Yakoub-Agha I
Am J Hematol; 2021 Jan; 96(1):69-79. PubMed ID: 33064301
[TBL] [Abstract][Full Text] [Related]
18. Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes.
Chhabra S; Narra RK; Wu R; Szabo A; George G; Michaelis LC; D'Souza A; Dhakal B; Drobyski WR; Fenske TS; Jerkins JH; Pasquini MC; Rizzo RD; Saber W; Shah NN; Shaw BE; Hamadani M; Hari PN
Biol Blood Marrow Transplant; 2020 May; 26(5):893-901. PubMed ID: 31982543
[TBL] [Abstract][Full Text] [Related]
19. Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT.
Polverelli N; Hernández-Boluda JC; Czerw T; Barbui T; D'Adda M; Deeg HJ; Ditschkowski M; Harrison C; Kröger NM; Mesa R; Passamonti F; Palandri F; Pemmaraju N; Popat U; Rondelli D; Vannucchi AM; Verstovsek S; Robin M; Colecchia A; Grazioli L; Damiani E; Russo D; Brady J; Patch D; Blamek S; Damaj GL; Hayden P; McLornan DP; Yakoub-Agha I
Lancet Haematol; 2023 Jan; 10(1):e59-e70. PubMed ID: 36493799
[TBL] [Abstract][Full Text] [Related]
20. Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study.
Rampotas A; Sockel K; Panitsas F; Theuser C; Bornhauser M; Hernani R; Hernandez-Boluda JC; Esquirol A; Avenoso D; Tsirigotis P; Robin M; Czerw T; Helbig G; Roddie C; Lambert J; McLornan DP
Transplant Cell Ther; 2023 Nov; 29(11):687.e1-687.e7. PubMed ID: 37633414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
